Standard screening tests: Pap smear – detects dysplasia, stage 0 cancer (carcinoma in situ), accuracy is operator-dependent (can miss cancer due to sampling error), HPV testing

  • An estimated 1500 new cases of cervical cancer were diagnosed in Canada in 2015.
  • The mortality rate for cervical cancer decreased by 2.3% per year between 2001 and 2010. The decrease in mortality rate has followed the reduction in the cervical cancer incidence over the same period of time. The latter is largely the result of Pap test screening, which has helped detect precancerous and malignant lesions at an earlier stage when treatment is more effective.
  • Screening appears to play more of a role in reducing cervical cancer mortality among women over the age of 30 years.

Additional facts & information:

5 Year Survival

  • Stage 0 – no data
  • Stages 1&2 – 91%
  • Stage 3 – 57%
  • Stage 4 – 17%

About 50% of cases are diagnosed late, at stage 3 or stage 4.